Long-term survival in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation

Critical Care Medicine

Volumn 45, Issue 10, 2017, Pages 1718-1725

  Enger, Tone Bull ^a   Philipp, Alois ^b   Lubnow, Matthias ^b   Fischer, Marcus ^b   Camboni, Daniele ^b   Lunz, Dirk ^b   Bein, Thomas ^b   Müller, Thomas ^b  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

acute lung injury; extracorporeal membrane oxygenation; long term survivors; respiratory insufficiency; survival analysis

Indexed keywords

CORTICOSTEROID; HEMOGLOBIN; HYPERTENSIVE FACTOR; LACTIC ACID;

ADULT; ARTICLE; COHORT ANALYSIS; DIALYSIS; DISEASE ASSOCIATION; EXTRACORPOREAL OXYGENATION; FEMALE; FOLLOW UP; GERMANY; GLASGOW OUTCOME SCALE; HEMATOLOGIC MALIGNANCY; HEMOFILTRATION; HOSPITAL DISCHARGE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM SURVIVAL; LUNG INSUFFICIENCY; LUNG MINUTE VOLUME; MAJOR CLINICAL STUDY; MALE; MEDIAN SURVIVAL TIME; ORGAN TRANSPLANTATION; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESUSCITATION; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SEVERE ACUTE LUNG FAILURE; VENOVENOUS EXTRACORPOREAL MEMBRANE OXYGENATION; AGE; EPIDEMIOLOGY; IMMUNOCOMPROMISED PATIENT; MIDDLE AGED; MORTALITY; ORGAN DYSFUNCTION SCORE; RESPIRATORY INSUFFICIENCY; YOUNG ADULT;

ADULT; AGE FACTORS; COHORT STUDIES; EXTRACORPOREAL MEMBRANE OXYGENATION; FEMALE; FOLLOW-UP STUDIES; GERMANY; GLASGOW OUTCOME SCALE; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MIDDLE AGED; ORGAN DYSFUNCTION SCORES; RESPIRATORY INSUFFICIENCY; YOUNG ADULT;

EID: 85030442940     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0000000000002644     Document Type: Article

References (34)

1. Peek GJ, Mugford M, Tiruvoipati R, et al; CESAR trial collaboration: Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): A multicentre randomised controlled trial. Lancet 2009; 374:1351-1363
2. Davies A, Jones D, Bailey M, et al; Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators: Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009; 302:1888-1895
3. Patroniti N, Zangrillo A, Pappalardo F, et al: The Italian ECMO network experience during the 2009 influenza A(H1N1) pandemic: Preparation for severe respiratory emergency outbreaks. Intensive Care Med 2011; 37:1447-1457
4. Pham T, Combes A, Rozé H, et al; REVA Research Network: Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: A cohort study and propensity-matched analysis. Am J Respir Crit Care Med 2013; 187:276-285
5. Combes A, Bacchetta M, Brodie D, et al: Extracorporeal membrane oxygenation for respiratory failure in adults. Curr Opin Crit Care 2012; 18:99-104
6. Karagiannidis C, Brodie D, Strassmann S, et al: Extracorporeal membrane oxygenation: Evolving epidemiology and mortality. Intensive Care Med 2016; 42:889-896
7. Rozencwajg S, Pilcher D, Combes A, et al: Outcomes and survival prediction models for severe adult acute respiratory distress syndrome treated with extracorporeal membrane oxygenation. Crit Care 2016; 20:392
8. Enger T, Philipp A, Videm V, et al: Prediction of mortality in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation: A prospective observational study. Crit Care 2014; 18:R67
9. Pappalardo F, Pieri M, Greco T, et al; Italian ECMOnet: Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: The ECMOnet score. Intensive Care Med 2013; 39:275-281
10. Schmidt M, Zogheib E, Rozé H, et al: The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. Intensive Care Med 2013; 39:1704-1713
11. Peek GJ, Elbourne D, Mugford M, et al: Randomised controlled trial and parallel economic evaluation of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR). Health Technol Assess 2010; 14:1-46
12. Jennett B, Bond M: Assessment of outcome after severe brain damage. Lancet 1975; 1:480-484
13. Christakou AP PI, Sidiras G, Nanas S. Functional Assessment Scales in a general intensive care unit. A review. Hospital Chron 2013; 8:164-170
14. Fernandez RR, Cruz JJ, Mata GV: Validation of a quality of life questionnaire for critically ill patients. Intensive Care Med 1996; 22:1034-1042
15. Oken MM, Creech RH, Tormey DC, et al: Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5:649-655
16. Müller T, Philipp A, Luchner A, et al: A new miniaturized system for extracorporeal membrane oxygenation in adult respiratory failure. Crit Care 2009; 13:R205
17. Human Mortality Database: University of California, Berkeley (USA), and Max Planck Institute for Demographic Research (Germany). 2016. Available at: http://www.mortality.org or http://www.humanmortality. de. Accessed December 6, 2016
18. ECLS Registry Report (January 2017) International Summary: ECMO Registry of the Extracorporeal Life Support Organization (ELSO). 2017. Available at: https://www.elso.org/Registry/Statistics/InternationalSummary. aspx. Accessed January 31, 2017
19. von Bahr V, Hultman J, Eksborg S, et al: Long-term survival in adults treated with extracorporeal membrane oxygenation for respiratory failure and sepsis. Crit Care Med 2017; 45:164-170
20. Weycker D, Akhras KS, Edelsberg J, et al: Long-term mortality and medical care charges in patients with severe sepsis. Crit Care Med 2003; 31:2316-2323
21. Cuthbertson BH, Roughton S, Jenkinson D, et al: Quality of life in the five years after intensive care: A cohort study. Crit Care 2010; 14:R6
22. Lone NI, Gillies MA, Haddow C, et al: Five-year mortality and hospital costs associated with surviving intensive care. Am J Respir Crit Care Med 2016; 194:198-208
23. Khandelwal N, Hough CL, Bansal A, et al: Long-term survival in patients with severe acute respiratory distress syndrome and rescue therapies for refractory hypoxemia. Crit Care Med 2014; 42:1610-1618
24. Niskanen M, Kari A, Halonen P: Five-year survival after intensive care-comparison of 12,180 patients with the general population. Finnish ICU Study Group. Crit Care Med 1996; 24:1962-1967
25. Wright JC, Plenderleith L, Ridley SA: Long-term survival following intensive care: Subgroup analysis and comparison with the general population. Anaesthesia 2003; 58:637-642
26. Williams TA, Dobb GJ, Finn JC, et al: Determinants of long-term survival after intensive care. Crit Care Med 2008; 36:1523-1530
27. Wang CY, Calfee CS, Paul DW, et al: One-year mortality and predictors of death among hospital survivors of acute respiratory distress syndrome. Intensive Care Med 2014; 40:388-396
28. Davidson TA, Rubenfeld GD, Caldwell ES, et al: The effect of acute respiratory distress syndrome on long-term survival. Am J Respir Crit Care Med 1999; 160:1838-1842
29. Mahoney FI, Barthel DW: Functional evaluation: The Barthel index. Md State Med J 1965; 14:61-65
30. Schag CC, Heinrich RL, Ganz PA: Karnofsky performance status revisited: Reliability, validity, and guidelines. J Clin Oncol 1984; 2:187-193
31. Hodgson CL, Hayes K, Everard T, et al: Long-term quality of life in patients with acute respiratory distress syndrome requiring extracorporeal membrane oxygenation for refractory hypoxaemia. Crit Care 2012; 16:R202
32. Li XY, Sun B, Wang CT, et al: A follow-up study on acute respiratory distress syndrome survivors after extracorporeal membrane oxygenation by pulmonary high-resolution CT. Arch Iran Med 2015; 18:6-11
33. Lindén VB, Lidegran MK, Frisén G, et al: ECMO in ARDS: A longterm follow-up study regarding pulmonary morphology and function and health-related quality of life. Acta Anaesthesiol Scand 2009; 53:489-495
34. Combes A, Leprince P, Luyt CE, et al: Outcomes and long-term quality-of-life of patients supported by extracorporeal membrane oxygenation for refractory cardiogenic shock. Crit Care Med 2008; 36:1404-141